Fact CheckerSign in

NCT06750224Enrolling by invitation

Comparative Effects of Alexander Techniques and Feldenkrais Method in Parkinson's Disease

Comparative Effects of Alexander Techniques and Feldenkrais Method on Balance, Fear of Fall and Quality of Life in Patients With Parkinson's Disease.

Source: ClinicalTrials.gov · Last updated 14 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Parkinson's disease (PD) is a neurodegenerative disorder characterized by tremors, rigidity, and postural instability. These symptoms significantly impact balance and increase the risk of falls, which subsequently lead to a heightened fear of falling and a diminished quality of life. Alexander Technique and the Feldenkrais Method have shown effects in improving overall well-being. The study is randomized clinical trial will be carried at General hospital. 46 participants meeting the inclusion criteria will be included in this study. Participants will be randomly assigned into 2 groups, Group A and Group B participants will receive Alexander techniques and Feldenkrais method, respectively. All the groups will receive interventions for three days a week for 8 weeks.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
46 (estimated)
First submitted
20 Dec 2024
Start date
1 Oct 2024
Primary completion date
1 Feb 2025
Lead sponsor
Riphah International University
NCT number
NCT06750224

What you commit to

  • Study type: Interventional
  • Planned participants: 46
  • From 1 Oct 2024 to the primary completion date, 1 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recent surgery or any fracture
  • CVS impairments that interfered with therapy
  • Joint pain or musculoskeletal problem that interfered with therapy

Other

  • Visual and hearing impairments.

Who the study is looking for

  • The age group of 50 to 70 years will be included.
  • Both genders (male and female)
  • Patients diagnosed with Parkinson's disease of Hoehn and Yahr stage (1-3).
  • Patient should be able to stand 10 minutes at least without assistance.
  • Patients should be able to walk with or without assistance.
  • MMSE (score higher than 24).

Age in the registry: 50 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
General hospital
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.